← Scroll for more →
Financial Statements — SCNI
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 1.66 | 0.99 | 1.96 | 3.08 | 4.87 | 7.51 | 10.80 | 14.08 | 39.50 | 17.38 | 10.74 |
| Accounts Receivable | 0.07 | 0.14 | 0.08 | 0.12 | 4.00 | -- | -- | -- | -- | -- | -- |
| Total Current Assets | 2.05 | 1.51 | 2.39 | 3.66 | 5.45 | 7.77 | 11.05 | 14.37 | 11.46 | 17.70 | 11.18 |
| Property, Plant & Equipment | 7.79 | 8.50 | 9.19 | 10.18 | 10.83 | 10.80 | 10.82 | 11.25 | -- | -- | -- |
| Total Non-current Assets | 9.57 | 10.33 | 11.06 | 11.19 | 12.03 | 12.13 | 12.25 | 12.70 | 12.99 | 44.55 | 13.91 |
| Total Assets | 11.63 | 11.84 | 13.45 | 14.85 | 17.47 | 19.90 | 23.29 | 27.07 | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- | -- | -- | 0.38 | -- | -- | -- |
| Total Current Liabilities | 1.59 | 2.12 | 1.81 | 1.67 | 1.78 | 1.89 | 2.58 | 2.34 | 23.52 | 7.21 | 21.76 |
| Total Non-current Liabilities | 1.94 | 1.86 | 1.67 | 20.46 | 20.26 | 25.12 | 25.52 | 26.49 | 16.45 | 69.06 | 6.57 |
| Total Liabilities* | 3.52 | 3.98 | 3.47 | 22.14 | 22.04 | 27.01 | 28.10 | 28.83 | -- | -- | -- |
| Retained Earnings | (125.85) | (121.67) | (117.54) | (126.82) | (122.33) | (123.11) | (119.35) | (115.83) | (110.58) | (117.29) | (109.64) |
| Total Stockholder Equity | 8.10 | 7.86 | 9.98 | (7.28) | (4.57) | (7.11) | (4.81) | (1.76) | 4.47 | 23.33 | 4.19 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2023 | Q2 2022 | Q3 2021 |
|---|---|---|---|---|---|---|
| Total Revenue | 0.23 | 0.28 | -- | -- | -- | -- |
| Cost of Revenue | 2.04 | 0.45 | -- | -- | -- | -- |
| Gross Profit | (1.27) | (0.16) | -- | -- | -- | -- |
| Research & Development | 1.24 | 2.79 | 1.45 | 2.00 | -- | -- |
| Selling, General & Admin | 1.26 | 1.00 | 1.14 | 1.19 | -- | -- |
| Total Operating Expenses | 2.49 | 3.79 | -- | -- | -- | -- |
| Operating Income | (3.76) | (3.95) | (2.59) | (3.19) | -- | -- |
| Net Income | (4.13) | (4.48) | (3.76) | (3.51) | -- | (9.05) |
| Basic EPS | -0.00 | -0.00 | -0.00 | -0.00 | (0.02) | (0.02) |
| Diluted EPS | -0.00 | -0.00 | -0.00 | -0.00 | (0.02) | (0.02) |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2023 | Q2 2022 | Q3 2021 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | (2.57) | (3.22) | (5.93) | (3.06) | (10.41) | (6.19) |
| Capital Expenditures | 0.01 | 0.01 | 0.38 | 0.01 | -- | -- |
| Free Cash Flow* | (2.59) | (3.23) | (6.32) | (3.06) | -- | -- |
| Investing Cash Flow | (0.01) | (0.01) | (0.38) | (0.01) | (0.08) | (0.01) |
| Financing Cash Flow | 1.58 | 1.43 | -- | -- | (0.47) | (0.99) |
← Scroll for more columns →
* Derived from reported values